Other proteins, such as kinases, crystalize more readily, allowing chemists to employ structure-based drug design to hone potency and selectivity. By contrast, GPCR drug discovery was largely ...

OMTX-705 is under clinical development by Oncomatryx Biopharma and currently in Phase I for Leiomyosarcoma. According to GlobalData, Phase I drugs for Leiomyosarcoma have a 92% phase transition ...

Sutro Biopharma, a drug development and manufacturing ... natural amino acids (nnAAs), which together allow for the precise design and rapid expression of homogeneous therapeutic bioconjugates ...

How to Implement an Effective Cleanroom Monitoring System In light of these potential problems, biopharma companies should ...

This page provides educational resources, events, news and products related to vaccine design and testing. Content will cover aspects from identifying vaccine targets, developing a vaccine and ...